| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.33▼ | 7.48▼ | 7.48▼ | 7.03▲ | 5.98▲ |
| MA10 | 7.41▼ | 7.54▼ | 7.41▼ | 6.69▲ | 5.05▲ |
| MA20 | 7.54▼ | 7.40▼ | 7.30▼ | 6.01▲ | 4.00▲ |
| MA50 | 7.43▼ | 7.14▲ | 6.72▲ | 4.85▲ | 2.82▲ |
| MA100 | 7.27▼ | 6.67▲ | 6.47▲ | 3.87▲ | 12.81▼ |
| MA200 | 6.80▲ | 6.18▲ | 5.43▲ | 2.98▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.048▼ | -0.042▼ | -0.030▼ | 0.067▲ | 0.419▲ |
| RSI | 23.052▼ | 44.781▼ | 49.706▼ | 67.892▲ | 75.438▲ |
| STOCH | 2.907▼ | 52.816 | 67.559 | 67.325 | 83.198▲ |
| WILL %R | -87.805▼ | -88.189▼ | -77.778▼ | -20.596▲ | -14.402▲ |
| CCI | -178.517▼ | -110.229▼ | -52.770 | 104.533▲ | 184.139▲ |
|
Wednesday, March 11, 2026 06:06 PM
Q32 Bio Inc. faces governance and reputational risk because its board, acting as administrator of the 2024 Plan, has broad discretion to reprice stock options, which it exercised in February 2025.
|
|
Tuesday, February 03, 2026 04:00 PM
Fintel reports that on February 25, 2026, HC Wainwright & Co. initiated coverage of Q32 Bio (NasdaqCM:QTTB) with a Buy recommendation. As of February 4, 2026, the average one-year price target for Q32 ...
|
|
Monday, December 01, 2025 01:43 AM
Q32 Bio on Monday sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics Inc. (NASDAQ: AKBA). ADX-097, the lead product candidate from Q32 Bio’s tissue-targeted complement inhibitor ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/03/26 | 7.09 | 7.85 | 7.022 | 7.14 | 362,889 |
| 25/03/26 | 7.28 | 7.525 | 6.85 | 7.25 | 244,409 |
| 24/03/26 | 6.74 | 7.3699 | 6.40 | 7.30 | 277,887 |
| 23/03/26 | 6.59 | 7.45 | 6.30 | 6.76 | 531,380 |
| 20/03/26 | 6.97 | 7.04 | 6.16 | 6.68 | 384,514 |
| 19/03/26 | 5.69 | 6.79 | 5.51 | 6.67 | 345,468 |
| 18/03/26 | 6.20 | 6.305 | 5.58 | 5.81 | 178,901 |
| 17/03/26 | 6.30 | 6.67 | 5.99 | 6.13 | 219,204 |
| 16/03/26 | 6.80 | 6.9075 | 6.14 | 6.30 | 337,464 |
| 13/03/26 | 7.21 | 7.80 | 6.55 | 6.82 | 405,974 |
|
|
||||
|
|
||||
|
|